Literature DB >> 15857353

Withdrawal syndrome following cessation of antihypertensive drug therapy.

G N Karachalios1, A Charalabopoulos, V Papalimneou, D Kiortsis, P Dimicco, O K Kostoula, K Charalabopoulos.   

Abstract

In this study, a review of the available information concerning abrupt withdrawal of antihypertensive drug therapy is presented. Abrupt withdrawal of these drugs can produce a syndrome of sympathetic overactivity that includes nervousness, tachycardia, headache, agitation and nausea 36-72 h after cessation of the drug. A withdrawal syndrome may occur after discontinuation of almost all types of antihypertensive drugs, but mostly occurs with clonidine, beta-blockers, methyldopa and guanabenz. Less commonly can produce a rapid increase of the blood pressure to pre-treatment levels or above, or both and/or myocardial ischaemia. Although the exact incidence of the syndrome is not known, it appears to be rare, at least in patients receiving standard doses of the above antihypertensive drugs. The best treatment is prevention. In this study regarding the withdrawal syndrome that follows cessation of antihypertensive drugs therapy, a reference to the abrupt discontinuation of the main categories of antihypertensive drugs is also attempted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857353     DOI: 10.1111/j.1368-5031.2005.00520.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  9 in total

1.  Dexmedetomidine: Are There Going to be Issues with Prolonged Administration?

Authors:  Joseph D Tobias
Journal:  J Pediatr Pharmacol Ther       Date:  2010-01

2.  Clonidine withdrawal induced sympathetic surge.

Authors:  Michael Shaw; Ramprasad Matsa
Journal:  BMJ Case Rep       Date:  2015-06-02

3.  β-blocker continuation after noncardiac surgery: a report from the surgical care and outcomes assessment program.

Authors:  Steve Kwon; Rachel Thompson; Michael Florence; Ronald Maier; Lisa McIntyre; Terry Rogers; Ellen Farrohki; Mark Whiteford; David R Flum
Journal:  Arch Surg       Date:  2012-05

4.  Effects of Clonidine on Withdrawal From Long-term Dexmedetomidine in the Pediatric Patient.

Authors:  Allison B Lardieri; Nicholas M Fusco; Shari Simone; L Kyle Walker; Jill A Morgan; Kristine A Parbuoni
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jan-Feb

Review 5.  Central sympatholytic drugs.

Authors:  Wanpen Vongpatanasin; Kazuomi Kario; Steven A Atlas; Ronald G Victor
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-07-18       Impact factor: 3.738

6.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

7.  Management of Acute Hypertensive Response in Patients With Ischemic Stroke.

Authors:  Ahmad AlSibai; Adnan I Qureshi
Journal:  Neurohospitalist       Date:  2016-04-21

Review 8.  Antihypertensive withdrawal for the prevention of cognitive decline.

Authors:  Susan Jongstra; Jennifer K Harrison; Terry J Quinn; Edo Richard
Journal:  Cochrane Database Syst Rev       Date:  2016-11-01

9.  Management of renin-angiotensin-aldosterone inhibitors and other antihypertensives and their clinical effects on pre-anesthesia blood pressure.

Authors:  Eda Balcı; Zeliha Aslı Demir; Melike Bahçecitapar
Journal:  Anesth Pain Med (Seoul)       Date:  2022-01-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.